Healthlead PCL (BKK:HL)
Thailand · Delayed Price · Currency is THB 5.75
-0.10 (-1.71%)
Jun 4, 2026, 4:37 PM ICT
Healthlead PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,244 | 2,229 | 1,977 | 1,636 | 1,520 | 1,199 |
Other Revenue | 41.79 | 41.07 | 34.35 | 23.77 | 18.69 | 17.62 |
| 2,286 | 2,270 | 2,011 | 1,659 | 1,538 | 1,216 | |
Revenue Growth (YoY) | 8.77% | 12.85% | 21.22% | 7.87% | 26.46% | 12.63% |
Cost of Revenue | 1,695 | 1,686 | 1,512 | 1,258 | 1,143 | 922.42 |
Gross Profit | 591.25 | 583.49 | 499.1 | 400.98 | 394.95 | 293.95 |
Selling, General & Admin | 489.73 | 480.85 | 410.04 | 306.94 | 249.52 | 191.31 |
Other Operating Expenses | -7.79 | -7.93 | -6.33 | -6.68 | -2.97 | - |
Operating Expenses | 481.94 | 472.92 | 403.71 | 300.26 | 246.55 | 191.31 |
Operating Income | 109.31 | 110.57 | 95.39 | 100.72 | 148.39 | 102.64 |
Interest Expense | -17.1 | -16.59 | -13.61 | -8.98 | -5.73 | -5.34 |
Interest & Investment Income | 4.68 | 4.68 | 8.02 | 2.87 | 0.17 | 0.04 |
Other Non Operating Income (Expenses) | -1.26 | -0.17 | 0.21 | -0.57 | - | - |
EBT Excluding Unusual Items | 95.64 | 98.5 | 90 | 94.04 | 142.83 | 97.35 |
Gain (Loss) on Sale of Assets | - | - | 6.45 | - | - | - |
Pretax Income | 95.64 | 98.5 | 96.46 | 94.04 | 142.83 | 97.35 |
Income Tax Expense | 19.69 | 20.64 | 18.19 | 19.36 | 24.61 | 17.68 |
Net Income | 75.94 | 77.86 | 78.26 | 74.68 | 118.23 | 79.66 |
Net Income to Common | 75.94 | 77.86 | 78.26 | 74.68 | 118.23 | 79.66 |
Net Income Growth | -5.25% | -0.52% | 4.80% | -36.84% | 48.41% | 52.98% |
Shares Outstanding (Basic) | 271 | 268 | 272 | 272 | 272 | 206 |
Shares Outstanding (Diluted) | 271 | 268 | 272 | 272 | 272 | 206 |
Shares Change (YoY) | 1.06% | -1.29% | - | - | 31.84% | 27.46% |
EPS (Basic) | 0.28 | 0.29 | 0.29 | 0.27 | 0.43 | 0.39 |
EPS (Diluted) | 0.28 | 0.29 | 0.29 | 0.27 | 0.43 | 0.39 |
EPS Growth | -6.24% | 0.79% | 4.80% | -36.84% | 12.57% | 20.02% |
Free Cash Flow | 152.9 | 161.05 | 14.2 | 9.72 | 16.07 | 72.44 |
Free Cash Flow Per Share | 0.56 | 0.60 | 0.05 | 0.04 | 0.06 | 0.35 |
Dividend Per Share | 0.220 | 0.220 | 0.170 | 0.150 | 0.180 | 0.280 |
Dividend Growth | 29.41% | 29.41% | 13.33% | -16.67% | -35.71% | 300.00% |
Gross Margin | 25.86% | 25.70% | 24.81% | 24.16% | 25.68% | 24.17% |
Operating Margin | 4.78% | 4.87% | 4.74% | 6.07% | 9.65% | 8.44% |
Profit Margin | 3.32% | 3.43% | 3.89% | 4.50% | 7.69% | 6.55% |
Free Cash Flow Margin | 6.69% | 7.09% | 0.71% | 0.59% | 1.04% | 5.96% |
EBITDA | 154.89 | 153.46 | 131.3 | 126.32 | 162.96 | 117.12 |
EBITDA Margin | 6.78% | 6.76% | 6.53% | 7.61% | 10.59% | 9.63% |
D&A For EBITDA | 45.58 | 42.89 | 35.92 | 25.6 | 14.57 | 14.48 |
EBIT | 109.31 | 110.57 | 95.39 | 100.72 | 148.39 | 102.64 |
EBIT Margin | 4.78% | 4.87% | 4.74% | 6.07% | 9.65% | 8.44% |
Effective Tax Rate | 20.59% | 20.95% | 18.86% | 20.58% | 17.23% | 18.16% |
Revenue as Reported | 2,286 | 2,270 | 2,018 | 1,659 | 1,538 | 1,216 |